» Articles » PMID: 37842661

Ginsenoside Rk2, a Dehydroprotopanaxadiol Saponin, Alleviates Alcoholic Liver Disease Via Regulating NLRP3 and NLRP6 Inflammasome Signaling Pathways in Mice

Overview
Journal J Pharm Anal
Specialty Chemistry
Date 2023 Oct 16
PMID 37842661
Authors
Affiliations
Soon will be listed here.
Abstract

Heavy alcohol consumption results in alcoholic liver disease (ALD) with inadequate therapeutic options. Here, we first report the potential beneficial effects of ginsenoside Rk2 (Rk2), a rare dehydroprotopanaxadiol saponin isolated from streamed ginseng, against alcoholic liver injury in mice. Chronic-plus-single-binge ethanol feeding caused severe liver injury, as manifested by significantly elevated serum aminotransferase levels, hepatic histological changes, increased lipid accumulation, oxidative stress, and inflammation in the liver. These deleterious effects were alleviated by the treatment with Rk2 (5 and 30 mg/kg). Acting as an nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inhibitor, Rk2 ameliorates alcohol-induced liver inflammation by inhibiting NLRP3 inflammasome signaling in the liver. Meanwhile, the treatment with Rk2 alleviated the alcohol-induced intestinal barrier dysfunction via enhancing NLRP6 inflammasome in the intestine. Our findings indicate that Rk2 is a promising agent for the prevention and treatment of ALD and other NLPR3-driven diseases.

Citing Articles

Potential Mechanisms and Effects of Dai Bai Jie Ethanol Extract in Preventing Acute Alcoholic Liver Injury.

Xia N, Xue H, Li Y, Liu J, Lou Y, Li S Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852118 PMC: 11763393. DOI: 10.3390/cimb47010003.


Ginsenoside Rk2 alleviates hepatic ischemia/reperfusion injury by enhancing AKT membrane translocation and activation.

Shen H, Fu J, Liu J, Zou T, Wang K, Zhang X MedComm (2020). 2025; 6(1):e70047.

PMID: 39811799 PMC: 11731106. DOI: 10.1002/mco2.70047.


Girard Derivatization-Based Enrichment Strategy for Profiling the Carbonyl Submetabolome in Biological Samples.

Tao X, Liu J, Zhou J, Dai J, Xiao Z, Li H Anal Chem. 2024; 96(52):20414-20424.

PMID: 39698855 PMC: 11696826. DOI: 10.1021/acs.analchem.4c04037.


Multifunctional carbomer based ferulic acid hydrogel promotes wound healing in radiation-induced skin injury by inactivating NLRP3 inflammasome.

Huang C, Huangfu C, Bai Z, Zhu L, Shen P, Wang N J Nanobiotechnology. 2024; 22(1):576.

PMID: 39300534 PMC: 11411768. DOI: 10.1186/s12951-024-02789-7.


- Complex Alleviates Alcoholic Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation: A Transcriptome and Gut Microbiota Analysis.

Gao R, Huang Q, Zeng Y, Chen D, Jia Z, Han B Foods. 2024; 13(15).

PMID: 39123621 PMC: 11311716. DOI: 10.3390/foods13152431.


References
1.
de Carvalho Ribeiro M, Szabo G . Role of the Inflammasome in Liver Disease. Annu Rev Pathol. 2021; 17:345-365. PMC: 10501045. DOI: 10.1146/annurev-pathmechdis-032521-102529. View

2.
Wlodarska M, Thaiss C, Nowarski R, Henao-Mejia J, Zhang J, Brown E . NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014; 156(5):1045-59. PMC: 4017640. DOI: 10.1016/j.cell.2014.01.026. View

3.
Peng Y, French B, Tillman B, Morgan T, French S . The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation. Exp Mol Pathol. 2014; 97(2):305-13. PMC: 4177273. DOI: 10.1016/j.yexmp.2014.08.006. View

4.
Le Dare B, Ferron P, Gicquel T . The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?. Int J Mol Sci. 2021; 22(4). PMC: 7926651. DOI: 10.3390/ijms22042139. View

5.
He Y, Varadarajan S, Munoz-Planillo R, Burberry A, Nakamura Y, Nunez G . 3,4-methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome. J Biol Chem. 2013; 289(2):1142-50. PMC: 3887181. DOI: 10.1074/jbc.M113.515080. View